WallStreetZenWallStreetZen

NASDAQ: SUPN
Supernus Pharmaceuticals Inc Stock Ownership - Who owns Supernus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Supernus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Frank MottolaSVP Chief Tech. Ops. Officer2025-09-125,000$39.40
$197.00kBuy
Frank MottolaSVP Chief Tech. Ops. Officer2025-09-125,000$45.87
$229.35kSell
Jack A. KhattarPresident CEO2025-09-086,322$46.29
$292.65kSell
Jack A. KhattarPresident CEO2025-09-088,074$25.30
$204.27kBuy
Jack A. KhattarPresident CEO2025-09-0573,176$25.30
$1.85MBuy
Jack A. KhattarPresident CEO2025-09-0555,578$46.01
$2.56MSell
Jack A. KhattarPresident CEO2025-08-2824,150$45.12
$1.09MSell
Jack A. KhattarPresident CEO2025-08-2838,779$12.98
$503.35kBuy
Charles W. Newhall IiiDirector2025-08-273,588$45.01
$161.50kSell
Jack A. KhattarPresident CEO2025-08-2710,650$45.05
$479.78kSell

1 of 9

SUPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SUPN insiders and whales buy or sell their stock.

SUPN Shareholders

What type of owners hold Supernus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter J. Barris21.15%11,859,518$539.13MInsider
Scott D. Sandell20.97%11,757,336$534.49MInsider
Forest Baskett20.95%11,746,274$533.99MInsider
Charles W. Newhall Iii19.21%10,770,894$489.64MInsider
Blackrock Inc16.71%9,367,894$425.86MInstitution
Vanguard Group Inc11.07%6,205,256$282.09MInstitution
Armistice Capital LLC8.58%4,812,000$218.75MInstitution
Krishna Kittu Kolluri6.85%3,841,172$174.62MInsider
New Enterprise Associates 11 LP6.81%3,820,625$173.69MInsider
Nea Partners 11 LP6.81%3,820,625$173.69MInsider

1 of 3

SUPN vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SUPN46.27%53.73%Net BuyingNet Buying
ALVO5.53%0.00%
BHC51.69%48.31%Net BuyingNet Buying
ANIP29.08%70.92%Net SellingNet Selling
INDV85.67%0.00%
View Top Pharmaceutical Stocks

Supernus Pharmaceuticals Stock Ownership FAQ

Who owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals (NASDAQ: SUPN) is owned by 106.03% institutional shareholders, 123.13% Supernus Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Supernus Pharmaceuticals shareholder, owning 11.86M shares representing 21.15% of the company. Peter J. Barris's Supernus Pharmaceuticals shares are currently valued at $521.70M.

If you're new to stock investing, here's how to buy Supernus Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.